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doi:10.1016/j.ejvs.2008.06.010Abstract Objectives: We reviewed the use of negative pressure wound treatment (NPWT) for
problematic wounds.
Methods: A systematic literature review was undertaken to assess the effectiveness and safety
of NPWT. Randomized controlled trials (RCTs) assessing NPWT were included.
Results: A total of 14 RCTs were included. Trials included patients with pressure wounds (2),
post-traumatic wounds (3), diabetic foot ulcers (4) and miscellaneous chronic ulcers (5). In
all trials NPWT was at least as effective and in some cases more effective than the control
treatment. Most evidence supports the effectiveness of NPWT on chronic leg ulcers and post-
traumatic ulcers. NPWT appears to be a safe treatment, and serious adverse events have been
rarely reported. Only two trials were classified as high quality studies, whereas the remaining
were classified as having poor internal validity.
Conclusions: Reliable evidence on the effectiveness of NPWT is scarce. Tentative evidence
indicates that the effectiveness of NPWT is at least as good as or better than current local
treatment for wounds. The need for large high-quality randomised studies is apparent.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Patients with problematic wounds constitute a significant
workload burden for health care organizations. SuccessfulrsityCentralHospital,Depart-
gery, P.O. Box340, 00029HUS,
4; fax þ358 9 47173548.
us.fi (P. Vikatmaa).
ty for Vascular Surgery. Publishetherapy should be based on knowledge of the wound
aetiology and the different features of the wound care
products available. Well-implemented randomised con-
trolled trials comparing different wound care products are
scarce.1,2
Negative pressure has been used as part of the treat-
ment of wounds in the form of various drains since the
1940s.3,4 The treatment technique for open wounds based
on negative pressure was developed in Germany and thed by Elsevier Ltd. All rights reserved.
NPWT, Systematic Review 439United States during the 1990s.5e7 Kinetic Concepts, Inc.
(KCI, Texas, US) has patented the method with the name
Vacuum Assisted Closure (V.A.C.). The generic English-
language name Negative Pressure Wound Therapy (NPWT)
is widely used. The treatment is based on evenly distrib-
uted local negative pressure applied to the wound surface.
The open wound is covered with a separate wound dressing
(polyurethane or polyvinyl alcohol) and an air-tight film.
The wound dressing is connected by means of a set of
suction tubes to a control unit by which the primary nega-
tive pressure on the surface of the wound can be adjusted.
Most commonly 80e125 mmHg of negative pressure is used,
either continuously or in cycles. The fluid suctioned from
the wound is collected into a container in the control unit
(Fig. 2).
NPWT has been recommended for virtually all kinds of
acute and chronic wounds to accelerate healing in pressure
wounds, diabetic leg ulcers, lower leg wounds, surgical
incision, traumatic wounds, burns, infected wounds, nec-
rotizing fascitis, infected sternal wounds and after skin
grafting (KCI marketing brochures and personal communi-
cation with company representatives). The duration of the
therapy varies from a few days to months, depending on
the treatment aim and the nature of the wound. The
literature analyzing the mechanisms believed to account
for the efficacy of NPWT therapy and the different possible
clinical benefits are analyzed in a recent review by Hunter
et al.8
The aim of this systematic review was to gather the most
reliable evidence available on the effectiveness and safety
of NPWT in the treatment of acute and chronic wounds.
Methods
Criteria for considering studies in the review
To be accepted into this analysis the study had to be
a randomised controlled trial in which NPWT was compared
with any other local wound therapy for any wound
indication.
Search methods for identification of studies
The literature search was conducted by an experienced
information analyst liaising with the research team. A
search was made with the words vac therapy, wound or
ulcer, vacuum or negative pressure or subatmospheric,
from Medline, Medline in-process, Pubmed and Cochrane
Controlled Trials Register from 1996 onwards. In addition,
systematic literature reviews were searched from the
following databases: Cochrane Database of Systematic
Reviews; Database of Abstracts of Reviews of Effectiveness,
NHS Economic Evaluation Database, and Health Technology
Assessment Database. The original studies found in the
reviews were included in the present systematic review.
Ongoing clinical trials were also sought from the U.S. and
UK registers (Clinicaltrials. gov, National Research Register/
metaRegister). A search was also made on the Aggressive
Research Intelligence Facility web site (http://www.arif.
bham.ac.uk/), as well as on the manufacturer’s web site
(http://www.kci1.com/). The references listed in thestudies that were eligible for review were checked in order
to find other possible articles. There were no language
restrictions. The searches were originally performed in
July 2006 and updated in January 2008. A more detailed
search strategy is available from the authors.
Data collection and analysis
Selection of articles
Two independent authors (VJ, PV) applied the selection
criteria to all citations identified by the search strategy
described above. The same authors made the final selec-
tion based on a review of full publications, which were
retrieved for all studies that either met the selection
criteria, or for which there was uncertainty regarding
selection. The reviewers were not blinded during the
selection process regarding authors of the articles or the
publication forum.
Data extraction and management
Two authors collected the basic data and results (VJ, PV) on
pre-planned data collection sheets. The data was sepa-
rately described for various types of wounds. In doing the
review and assessing the articles, established international
criteria set for systematic reviews, were employed.9
Two authors (AM and PK) complemented the study
quality assessment results presented in the U.S. Agency
for Healthcare Research and Quality report10e16 by assess-
ing the quality of the additional trials in the present re-
view.17e23 The information of the source of funding of the
trials was extracted.Results
Search results
From the electronic searches we identified 68 citations
for systematic reviews and 187 citations for original
publications. After evaluation of the full text publications
retrieved, ten systematic literature reviews were discov-
ered,10,24e32 and eight RCTs11e17,19 were considered eligi-
ble for the review. From reference lists of reviewed
papers, conference presentations and control searches,
a further five17,18,21e23 RCTs were identified during the
review process and added in the analysis. One publica-
tion21 reported two separate trials and thus fourteen
RCTs were reported. (Fig. 1)
Methodological quality and sources of
funding of the trials
The methodological quality of the trials was poor in most
studies. Two trials were considered to have good internal
validity (Table 1). In eight publications, the researchers re-
ported that they had received economic support from the
manufacturer of the NPWT, Kinetic Concepts, Inc.12e
15,17,18,21,22 In four publications, data on funding was not re-
ported.11,16,19,20 In one trial the authors declared that they
had no conflict of interest with any of the manufacturing
companies.23 (Table 1)
Figure 2 Schematic drawing of the negative pressure wound
treatment (NPWT). Published with the permission from Suomen
La¨a¨ka¨rilehti (Finnish Medical Journal).
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NPWT
Randomised controlled trials were found with respect to
pressure ulcers,12,16 post-traumatic wounds,21,23 diabetic
foot ulcers11,14,17,19 as well as acute and chronic ulcers
with various aetiologies.13,15,18,20,22 Characteristics of pa-
tients, interventions and comparative treatments are
shown in Table 2, and effectiveness data in Table 3.
NPWT and pressure ulcers12,16
In two studies dealing with the treatment of deep pressure
wounds, NPWT was compared with traditional wound care
with gel products or moist bandages. No significant differ-
ence was noted in the outcome of a 22-patient study by
Wanner et al. The NPWT group took a mean (SD) of 27 (10)
days and the moist bandage group 28 (7) days to half the
wound volume.16 In another 28-patient study by Ford
et al., there was no statistically significant difference in
outcomes. Complete healing was reached in 4 patients (2
vs. 2) within the 6 week study period. The mean percentage
reduction in ulcer volume was 42% with gel products and
52% with NPWT (pZ 0.46).12
NPWT and post-traumatic wounds21,23
In two separate 44-patient studies reported in one publi-
cation, by Stannard et al., the influence of NPWT on the
amount of wound exudate after surgery was evaluated. Af-
ter incision of traumatic haematomas (part A), exudation of
the wound ceased earlier in the NPWT group than in theReference lists and own files
(i.e. searches performed
outside the systematic
literature search):
5 RCTs  
Search results:
187 potential RCTs
68 systematic review
Final inclusion:
14 RCTs in 13 publi
10 systematic review
Full assessment:
25 potential RCTs
10 systematic review
Figure 1 Flow diagram for screening process. RCTZ randomizedpressure dressing group (1.6 [0e5] vs. 3.1 [0e11] days,
pZ 0.03). Wound infection or breakdown rates did not dif-
fer in this study. In the study concerning operated complex
fractures in the lower extremities (part B), faster reduction
in wound exudate was noted in the NPWT than with the pa-
tients treated by means of traditional dressing (1.8 [0e6]
vs. 4.8 [0e28] days, pZ 0.02). On the other hand, the num-
bers in need of repeat surgery (1 [8%] vs. 5 [16%], ns) or
those with wound infections (0 vs. 1, ns) did not show anyExcluded by titles and abstracts:
167 original publications
58 systematic reviews   
cations
s
Excluded by full texts: 12,
Not a RCT on NPWT (10)
Not comparable groups, different
usage of artificial skin (1)  
s   
controlled trial. NPWTZ negative pressure wound treatment.
Table 1 Methodological quality of the trials*
Author, publication year, country Initial assembly
of comparable
groups
Low loss to follow-up,
maintenance of
comparable groups
Measurements
reliable, valid,
equal
Interventions
comparable/
clearly defined
Appropriate
analysis of
results
Overall
rating
Support
obtained from
the industry (KCI)
Armstrong et al., 2005, USA17 Partial No Partial Yes No Poor Yes
Braakenburg et al., 2006,
Netherlands18
Partial No Partial Yes Partial Poor Yes
Eginton et al., 2003, USA11 ? No Yes Yes No Poor No
Eto¨z et al., 2004, Turkey 19 No ? No Yes ? Poor Not reported
Ford et al., 2002, USA12 ? No Yes Yes No Poor Yes
Joseph et al., 2000, USA13 ? ? Yes Yes Partial Poor Yes
Llanos et al., 2006, Chile23 Yes Yes Yes Yes Yes Good No
Moues et al., 2004, Netherlands15 Partial ? No Yes No Poor Yes
McCallon et al., 2000, USA14 ? ? No Yes No Poor Yes
Stannard et al., 2006, USA (a)21 ? ? ? Partial ? Poor Yes
Stannard et al., 2006, USA (b)21 ? ? ? Partial ? Poor Yes
Moisidis et al., 2004, Australia 20 No No Partial Yes No Poor Not reported
Wanner et al, 2003, Switzerland16 ? ? Partial Yes No Poor Not reported
Vuerstaek, et al., 2006
Netherlands, Belgium22
Yes Yes Yes Yes Yes Good Yes
AHRQ Publication No. 05-E005-2. Rockville, MD: Agency for Healthcare Research and Quality. December 2004.
* According to the method in: Samson D J, Lefevre F, Aronson N. Wound-healing technologies: low-level laser and vacuum-assisted closure. Evidence Report/Technology Assessment
No. 111.
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Table 2 Characteristics of patients, interventions and comparative treatments. The studies are grouped according to the cer type.
Reference, year,
country
No. of patients
(ulcers)
Men, % Age, mean Follow-up,
months
Main inclusion criteria Intervention ) Comparative treatment (n)
Pressure ulcers
Ford et al.12 28 (35) not
reported
T: 41.7,
C: 54.4
10 Full-thickness pressure ulcers
(Grade III-IV) for 4 weeks or
more
V.A.C., dres ng change
three times a eek (20
ulcers)
Gel-products (Iodosorb,
Iodoflex or Panafil,
Healthpoint System), dressing
changes one to two times a day
(15 ulcers)
Wanner et al.16 22 68.2 T: 49,
C: 53
0.7e1.7 Deep pressure ulcers of pelvic
region in paraplegic or
tetraplegic patients
V.A.C., dres ng change
after two to ven days (11)
wet-to-dry/wet-to-wet gauze
dressings soaked with Ringer´s
solution, dressing changes one
to three times a day (11)
Post-traumatic wounds
Stannard et al. (part A)21 44 82 48 6e20,
mean 8
Haematoma in a closed surgical
incision which is draining at
least 5 days after trauma
surgery
V.A.C., dres ng change
every 48hour r more often
(13)
Pressure dressing, changed
once a day (31)
Stannard et al. (part B)21 44 73 41 6e20,
mean 9.2
Adjunct to healing of surgical
incisions after high energy
fractures (calcaneus, pilon
tibiale, tibial plateau)
V.A.C., dres ng change
every 48 hou ? (20)
Standard postoperative
dressing, changed once a day?
(24)
Llanos et al.23 60 83.3 T:34.0,
C:34.5
T:0.3,
C:0.4
Acute traumatic wounds with
hindered primary closure, low
bacterial count and need for
skin grafting
‘‘Home made wound
covering with olyurethane
sheets and ce tral
aspiration sys m at -80
mmHg, 4 day (30)
Same as in intervention, but
tubing not connected to
suction (30)
Diabetic foot ulcers
Armstrong et al.17 162 81 T:57.2,
C:60
3.7 Partial foot amputation wounds
up to transmetatarsal level and
evidence of adequate perfusion
(ABI 0.7e1.2 and toe
pressure 30 mmHg or
transcutaneous oxygen
pressure 30 mmHg on the
dorsum of the foot)
V.A.C., dres ng change
every 48hour (77)
Standard moist wound care like
alginates, hydrocolloids, foams
or hydrogels, dressing change
in most cases daily (85)
Eginton et al.11 10 (crossover
design)
not
reported
not
reported
1 Diabetic foot ulcers of a size
not expected to heal in one
month, adequate perfusion
(palpable pulses or toe
pressure> 40 mmHg)
V.A.C., dres ng change
three times a eek (10)
Hydrocolloid wound gel and
gauze dressings, changed once
a day (10)
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Eto¨z et al.19 24 88 T:66.2,
C:64.7
T:0.38,
C:0.53
Nonhealing wounds in the
lower extremity of diabetic
patients
‘‘Home made’’
polyurethane dressing and
medical aspiration system
(Bicakcilar Inc.), dressing
change every 48hours (12)
Saline-moistened gauze
dressing, changed twice a day
(12)
McCallon et al.14 10 not
reported
T: 55.4,
C: 50.2
1.5 Non healing diabetic foot
ulcers for longer than 4 weeks
V.A.C., dressing change
every 48 hours (5)
Saline-moistened gauze
dressing, changed twice a day
(5)
Ulcers of various etiology
Braakenburg et al.18 65 55 T:65.5,
C:69.2
T: 1.9;
C:2.3
Acute or chronic wound of any
aetiology
V.A.C., dressing changes
three times a week (32)
Standard modern wound
treatment with various
dressings (hydrocolloid,
alginate, acetic acid or sodium
hypochlorite), dressing changes
one or more times a day (33)
Joseph et al.13 24 (36) 54.2 T: 56,
C: 49
1.5 Chronic (>4 weeks) non healing
wounds of various aetiology
V.A.C., dressing change
every 48hours (18)
Wet-to-moist saline gauze
dressings, changed three times
a day (18)
Moisidis et al.20 20 (wounds
divided in two
halves for
randomization)
60 59.8 0.5 Acute and chronic wounds
treated by split thickness skin
graft. Wound area 25cm2 or
larger
V.A.C., 100mmHg for five
days, then daily petroleum
gauze (20)
Silicone-dressing (Mepitel),
Acroflavine wool and standard
foam for five days, then daily
petroleum gauze (20)
Moues et al.15 54 64.8 T: 47.7,
C: 47.9
1 Acute and chronic wounds
needing wound management
before surgical closure
V.A.C., dressing change
every 48hours (29)
Moist gauze dressings, changed
twice or more times a day (25)
Vuerstaek et al.22 60 23 T:74, C:72 12 Chronic leg ulcers (venous,
combined venous and arterial
or arteriosclerotic) of >6
months duration and >6
months extensive treatment in
outpatient clinic has failed.
V.A.C. until clean
granulating wound bed.
Punch skin grafting (30)
Daily local wound care
according to SIGN guideline and
compressive therapy until
clean granulating wound bed.
Punch skin grafting (30)
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Table 3 Results: effectiveness on primary and secondary outcomes.
Reference No. of
patients
(ulcers)
Primary outcome
measure (p.o.m)
Effect on p.o.m. Secondary outcome
measure (s.o.m.)
Effect on s.o.m. Adverse effects
NPWT Control p NPWT Control p
Pressure ulcers
Ford et al.12 28 (35) Total healing, healed
ulcers/n
2/20 2/15 ns Reduction in ulcer
volume (%)
42.1% 51.8% 0.46 T: One lower
leg amputation
Wanner et al.16 22 Time to halve the
wound volume,
mean (SD)
27 (10) 28 (7) 0.9 Not reported
Post-traumatic ulcers
Stannard et al.
(part A)21
44 Cessation of drainage
in days, mean (range)
1.6
(0e5)
3.1
(0e11)
0.03* Haematoma infection
requiring surgery (n/N)
1/13 5/31 ns See s.o.m.
Late infection (n/ total N) 0/13 1/31 ns
Stannard et al.
(part B)21
44 Time to reach minimal
incision drainage, days,
mean (range)
1.8
(0e6)
4.8
(0e24)
0.02* Wound infection (n/N) 3/20 3/24 ns See s.o.m.
Wound breakdown 1/20 1/24 ns
Llanos et al.23 60 Area of skin graft loss
in cm2 at 4 days,
median (range)
0.0
(0.0e11.8)
4.5
(0e52.9)
0.001* Need for regrafting (n/N) 5/30 12/30 0.045* No pneumonia
or other
complications
Days from grafting to
discharge, median
(range)
8
(7e13)
12
(7e23)
0.001*
Diabetic foot ulcers
Armstrong
et al.17
162 100% re-epithelialisation,
before 112 days (n/N)
43/77 33/85 0.04* Granulation change from
0e10% to 76e100%, median,
days (IQR) (nZ 19 vs 15)
42
(40e56)
84
(57e112)
0.002* T: 12%, C: 13%
(most
commonly
infection)
time needed to 100%
re-epithelialisation,
days, mean (range)
56
(26-92)
77
(40e112)
0.005* Second amputation (n/N) 2/77 9/85 0.06
High level (below or above
knee) amputation
0/77 5/85 0.06
Eginton et al.11 10 Wound volume
decrease % (SD)
59%
(9.7)
0.1%
(14.7)
<0.005* Wound area % (SD) 16.4%
(6.2)
5.9%
(17.4)
ns Not reported
Eto¨z et al.19 24 Wound covered by
granulation, days mean
11.3 15.8 0.005* Wound area cm2 20.4 9.5 0.032* T: minor
bleeding
McCallon
et al.14
10 Definitive closure
(ready for surgery or
secondary healing),
days (SD)
22.8
(17.4)
42.8
(32.5)
no
statistical
analysis
Reduction in ulcer
area % (SD)
28.4%
(24.3)
9.5% 16.9 no
statistical
analysis
Not reported
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Ulcers of various etiology
Braakenburg
et al.18
65 Wound-healing time,
days, median (95%CI)
16
(9e23)
29
(16e24)
0.32 Wound-healing time for
the cardiovascular and
diabetic patients, days,
median (95%CI)
14 (9e19)
(nZ 23)
23 (18-28)
(nZ 18)
0.06 2 NPWT
treatments
discontinued
due to pain
Change in granulation %/day 1.7% 1.6% ns
Wound surface area cm2/day 0.1 0.1 ns
Joseph et al.13 24 Reduction in wound
volume at 6 weeks, %
78% 30% 0.038* Ulcer width reduction
at 6 weeks, %
64% 35% 0.02 Variety of mild
adverse
effects: T: 17%,
C:55%,
pZ 0.0028
Moisidis et al.20 20 Skin graft take 100%
at 2 weeks n/ total N
6/20 7/20 ns Qualitative graft take
better than comparison,
n/total N
10/20 3/20 p< 0.05* Not reported
Moues et al.15 54 Wound ‘‘ready for
surgical therapy’’,
days, median (SEM)
6.0
(0.52)
7.0
(0.81)
0.19 Decrease in ulcer area,
%, days (SEM)
3.8 (0.5)
(nZ 15)
1.7 (0.6)
(nZ 13)
ns Not reported
Bacterial count> 1 106
end of at treatment, %
42% 42% ns T: 40% (mostly
pain and skin
irritation), C:
23%, ns
Vuerstaek
et al.22
60 Complete healing,
days (95% CI)
29
(25.5e32.5)
45
(36.2e53.8)
0.0001* Wound preparation time,
days (95 CI)
7
(5.7e8.3)
17
(10e24)
0.005*
Wound relapse at 1 year % (n) 52% (12) 42% (10) 0.47
Succesful skin grafts % (SD) 83 % (14) 79% (31) 0.011*
*Z statistical significance p 0.05.
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446 P. Vikatmaa et al.significant differences between the treatment and control
groups. 21 (Table 3)
Llanos et al. randomized 60 patients with acute trau-
matic injuries and skin loss, which needed skin grafting.
The randomisation was performed after the split thickness
skin grafting and the dressing of the wound (Table 2). At
four days the wounds were photographed and the final
analysis from the photographs was made by a blinded ob-
server. The main outcome measure, loss of the skin graft
in cm2, was significantly smaller in the treatment group
(0.0 [0.0e11.8] vs. 4.5 [0e52.9] cm2, pZ 0.001). Need for
a second coverage procedure was less common in the treat-
ment group (5 [16.7%] vs. 12 [40.0%] patients, pZ 0.045).
Also the time in days from the procedure to discharge
from the unit was shorter when the suction was connected
(8 [7e13] vs. 12 [7e23] days, p< 0.001).23
NPWT and diabetic foot ulcers11,14,17,19
Armstrong et al. studied transmetatarsal amputation
wounds in 162 patients by comparing NPWT with modern
moist wound treatment.17 The foot had to have sufficient
blood circulation as determined by transcutaneous oxyme-
try (tcpO2 30 mmHg) or toe pressure measurement
(30 mmHg). More patients reached a 100% re-epitheliali-
sation. with or without secondary surgical intervention, in
the NPWT group than in the control group (43 [56%] vs. 33
[39%], pZ 0.04). In the patients who reached complete
closure, the rate of wound healing was faster in the
NPWT group (56 vs. 77 days, pZ 0.005). In the NPWT
group, 2 (3%) of the patients needed further surgical revi-
sion or amputation, whereas this number was 9 (11%) in
the control group (pZ 0.06). Above ankle level amputa-
tions were done in 5 (6%) of the control group patients,
whereas none of the treatment group patients were sub-
jected to a high amputation (pZ 0.06). However, these
differences in revisions and amputations were not statisti-
cally significant and could not directly be attributed to
NPWT treatment.
In a 24-patient study by Eto¨z et al., on diabetic foot
ulcers, the formation of granulation tissue in the NPWT
was faster (11.3 vs. 15.8 days, pZ 0.04), and the surface
area of the ulcer diminished more (20.4 vs. 9.5 cm2,
pZ 0.03) than with patients treated by saline bandages.19
In a cross-over trial of 10 patients, Eginton et al. compared
NPWT with moist wound treatment.11 The volume of the
ulcer diminished more in the NPWT group (59% [SD 9.7]
vs. 0.1% [14.7], p< 0.005), but there was no significant
surface area reduction (16.4% [SD 6.2] vs. þ5.9% [17.4],
ns) during 1 month of follow-up. In another 10-patient study
by McCallon et al., with a 6 week follow-up, there was no
difference between the patients treated with NPWT or
moist bandages in the time required to heal the ulcer
(22.8 [SD 17.4] vs. 42.8 [32.5] days) or with respect to
change in the ulcer surface area (28.4% [SD 24.3] vs.
þ9.5% [16.9]).14
NPWT and etiologically different wounds13,15,18,20,22
In a 24-patient study by Joseph et al., dealing with various
chronic wounds, NPWT was compared with local treatment
with moist saline gauzes. Wound volume declined substan-
tially more in the NPWT group (78% vs. 30% at 6 weeks,
pZ 0.038).13 Moisidis et al. studied the healing of skingrafting used for different indications in 20 patients. In
the study each skin graft area was divided into two: one
half was treated with negative pressure, and the other
with traditional compression bandages. At two weeks, a cli-
nician blinded to the randomisation evaluated both halves
of the wounds. The quality of the skin graft in the wound
halves treated with negative pressure was significantly bet-
ter in 10 patients, equally good in 7 patients and better in
the moist bandage group in 3 patients (p< 0.005). On the
other hand, no significant difference between the groups
in the quantitative degree of epithelisation was found. 20
In a 54-patient study by Moues et al., NPWT was compared
with moist bandages in the treatment of acute and chronic
wounds requiring surgical attention. There was no signifi-
cant difference between the groups in the formation of
granulation tissue or bacterial count in the wounds, but
the surface area of the wounds diminished more with
NPWT (3.8 0.5 SEM vs. 1.7 0.6 SEM %/day, p< 0.05).15
In a 65-patient study, the time to the primary endpoint of
wound healing was not significantly shorter in NPWT group
than in the moist bandage group (16 days [95% CI: 9e23]
vs. 20 [16e24], ns). Also, no significant difference was
obtained in wound granulation (1.7% vs. 1.6%/day, ns) or
surface area change (0.1 vs. 0.1 cm2/day, ns) when
NPWT was compared to moist wound treatment in the
care of acute and chronic wounds.18
In a Dutch study by Vuerstaeck et al., 60 patients with
a leg ulcer were again treated with either NPWT or moist
dressings.Negative Pressure Wound Therapy was contrasted
with moist wound treatment on lower leg ulcer patients in
materials concerning 60 Dutch patients, on whom skin graft
operations had been performed due to their ulcers. The
patients had three types of etiologically different ulcers:
Venous; combined venous and arterial; and arterial, but
these etiological groups were too small to be analysed sep-
arately. Patients accepted into the study were those whose
ulcers had not healed within six months. The endpoint was
the time required for complete healing of the ulcer. The
median time to complete healing was 29 days (95% CI,
25.5e32.5) in the NPWT group and 45 days (95% CI, 36.2e
53.8) in the control group (p< 0.0001). Prior to surgery,
the treatment aim was complete granulation of the ulcers,
and this was also reached more quickly in the NPWT group
(7 [95% CI, 5.7e8.3] vs. 17 [10e24] days, pZ 0.005). The
median percentage of successful skin grafts differed signif-
icantly between the NPWT and control groups, with
83% 14% vs. 79% 31% (pZ 0.011). On the other hand,
no significant difference was shown between the groups
in re-occurrence of the ulcers at 1 year (52% [nZ 12] vs.
42% [nZ 10], pZ 0.47).22Adverse events
In six studies out of fourteen, no adverse events were
reported (Table 3). Adverse events associated with NPWT
were described as infection, irritation of the skin and
pain when changing the dressing. Armstrong et al. reported
13 (17%) wound infections, but none of these were treat-
ment related and thus no further conclusions were
made.17 More serious complications associated with the
treatment were seldom reported and no clear difference
NPWT, Systematic Review 447between NPWT and other therapies could be noted in terms
of the prevalence of adverse events.
Costs and cost effectiveness
Two Dutch studies attempted to prospectively calculate the
costs between NPWT and modern products for wound
treatment.18,22 In one study, the costs for NPWT were in
similar to control treatment.18 In a further study, the costs
of NPWT were less than that of the reference therapy, but
the extent to which equipment outlay, for instance, was
taken into consideration remained unclear in the cost
analysis.22
Llanos et al. used a home made, inexpensive, wound
dressing ($4 per unit). The authors of this paper concluded
that as this inexpensive method seems effective, it should
be used routinely as a coadjuvant treatment.23Discussion
During the last few years, the use of NPWT has increased
substantially. This appears to be based on the marketing of
the available technology and favourable clinical
experiences.
This therapy does not replace surgical wound debride-
ment, measures to improve blood circulation nor relevant
treatment of infection. There must be no significant in-
fection or gangrene in the wound, when NPWT is initiated.
Caution is also warranted if there is a risk of bleeding from
the wound.
On the basis of our systematic review, NPWT appears to
be at least as effective and, under certain circumstances,
more effective than other available local wound treat-
ments. However, the interpretation of the research data is
hampered by both the diversity of the study designs and the
methodological weaknesses in the studies. In the rando-
mised controlled trials published, the entry criteria, follow-
up periods and outcome variables have varied greatly. With
the exception of one report,17 there have been only a limited
number of patients in the studies, and all studies have had
limitations with respect to the reliability of their findings.
Most promising results of NPWT have been obtained on
patients with lower leg ulcers that are vascular in origin as
well as diabetic foot ulcers, in which there is sufficient
blood supply. Split thickness skin graft healing seems to be
improved by NPWT. Publications on the use of NPWT in
other indications exist, but we included only RCTs in our
review. Svensson et al. reported recently their experience
with exposed vascular grafts and confirmed that they are
going to publish a RCT on this approach, although this tech-
nique is not recommended by the manufacturer.33
Adverse events associated with NPWT were mild or were
not reported at all. When correctly implemented and as
part of an overall wound treatment, NPWT appears to be
safe.
The cost effectiveness of NPWT depends on both the
public health care system and local operational practices.
The therapy would seem to be cost effective only under the
condition that it accelerates the healing of the wound when
compared to traditional treatment. Calculations made inone country may not be generalized in other countries.
When assessing the costs, the disposable materials required
for the change of dressing in addition to the price or rental
rate of the unit should be taken into account.30,32 The
emergence of new devices will probably decrease these
costs. The longer dressing change intervals enabled by
NPWT may reduce overall working time spent in caring for
the wound as well as material-related expenses.
The use of locally developed wall-suction unit systems is
based on an attempt to avoid the costs of the expensive
technology. One study on split thickness skin grafts used
a home-made negative pressure suction system. This trial
was methodologically of high quality, the intervention
proved to be effective, and the costs of the technology
were very small.23 The other study that used a home made
NPWT system had serious methodological problems, how-
ever it did also show a positive effect on wound healing.19
Systematic review is regarded as the most reliable
method of acquiring information on the effectiveness and
safety of a treatment. In preparing this review, the in-
ternational recommendations9 set for a systematic review
have been applied. Due to the heterogeneity of the indica-
tions and outcome measures neither a qualitative best
evidence synthesis nor a quantitative meta-analysis was
feasible.
Publication bias is the most significant source of bias in
any kind of literature survey, including systematic surveys.
This bias is particularly substantial when most of the studies
available are supported by companies marketing the
treatment method concerned. In fact this potential bias
has been confirmed in a recent systematic review.34
Conclusions
There is a shortage of reliable research data on the
effectiveness of NPWT. Tentative evidence indicates that
the effectiveness of such therapy is at least as good as or
better than current local treatment for wounds. This
appears to include the use of an inexpensive home-made
negative pressure suction system. The generalisation of the
cost-effectiveness data is hampered by differences in
treatment settings and health care systems.
NPWT does not replace basic methods of wound treat-
ment such as wound debridement, the treatment of in-
fection, the reduction of pressure in the area of the wound
and ensuring adequate blood supply.
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